Subgroup | HR (95% CI) | P value for interaction |
Primary outcome: all-cause mortality | ||
All patients | ||
Sex | 0.031 | |
Male | 1.40 (1.14 to 1.73) | |
Female | 0.95 (0.72 to 1.27) | |
Age group | 0.020 | |
Age <65 | 1.69 (1.22 to 2.35) | |
Age ≥65 | 1.07 (0.88 to 1.31) | |
Acute coronary syndrome | 0.806 | |
No | 1.31 (0.85 to 2.02) | |
Yes | 1.22 (1.02 to 1.47) | |
NSTE-ACS | 1.18 (0.97 to 1.44) | 0.506 |
STEMI | 1.42 (0.81 to 2.49) | |
Chronic kidney disease | 0.192 | |
No | 1.04 (0.78 to 1.39) | |
Yes | 1.31 (1.07 to 1.62) | |
Baseline anaemia | 0.854 | |
No | 1.17 (0.82 to 1.66) | |
Yes | 1.21 (1.00 to 1.47) |
Patients with major bleeding only compared with myocardial infarction only.
NSTE-ACS, non-ST elevation acute coronary syndrome; STEMI, ST elevation myocardial infarction.